EUVIMEDEUVIMED entdecken
Crossref

Disruptive Mood Dysregulation Disorder and Its Association with Treatment Trajectories and Outcomes in Youth with Attention-Deficit/Hyperactivity Disorder and Internalizing Disorders

Raman Baweja iD, Daniel A Waschbusch iD, Gabrielle A Carlson, James G Waxmonsky

Journal of Child and Adolescent Psychopharmacology · 01.10.2026 · 36 (8) · 473-482

DOI: 10.1177/10445463261428442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 10.03.2026. Verfasst von Raman Baweja und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Mood Disorders, Anxiety Disorders, Major Depressive Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Disruptive mood dysregulation disorder (DMDD), along with other internalizing disorders, is associated with greater impairment in youth with attention-deficit/hyperactivity disorder (ADHD). However, it remains unclear whether DMDD is associated with differences in treatment course and outcomes among youth with ADHD and comorbid internalizing disorders. Using real-world data, this study compared treatment patterns and clinical outcomes among youth with ADHD and internalizing disorders with and without comorbid DMDD.

Methods

A retrospective cohort study analyzed electronic health records from the TriNetX U.S. Collaborative Network, including 340,225 youth aged 6–18 years with ADHD and at least one internalizing disorder (major depressive disorders or anxiety disorder), of whom 25,580 (7.5%) had comorbid DMDD. Outcomes included treatment patterns and clinical outcomes. Propensity score matching and Cox proportional hazards models adjusted for confounding were used to estimate relative risks (RR), adjusted hazard ratios (aHR), and 95% confidence intervals (CI) over 1 year.

Results

Youth with ADHD, internalizing disorders, and DMDD exhibited greater psychiatric comorbidity and higher healthcare utilization than those without DMDD. They received more ADHD medications, with a marked shift toward nonstimulants (RR 1.73, 95% CI 1.69–1.77), and other psychotropic medications, including antidepressants, antipsychotics, and mood stabilizers (RR range 1.36–3.02). New central nervous system (CNS) stimulant prescriptions did not differ between youth with and without DMDD. Compared with nonstimulants, CNS stimulants were associated with lower risks of all adverse outcomes—including suicidal ideation/attempts, inpatient hospitalization, emergency visits, and subsequent antipsychotic or mood stabilizer initiation—in youth both with and without DMDD (aHR range 0.33–0.73).

Conclusions

Comorbid DMDD adds clinical complexity among youth with ADHD and internalizing disorders, influencing treatment patterns toward nonstimulants and other psychotropics. Despite this shift, CNS stimulants were associated with the most favorable outcomes across cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityMood DisordersAnxiety DisordersMajor Depressive DisorderHumansChildAdolescentFemaleRetrospective StudiesMaleComorbidityTreatment OutcomeCohort StudiesPropensity ScoreCentral Nervous System StimulantsUnited StatesElectronic Health Records

Stichwörter der Autor:innen

ADHDDMDDclinical outcomesinternalizing disorderspsychopharmacology

Substanzen

Central Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, Pennsylvania, USA.
  • Division of Child and Adolescent Psychiatry, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.

ORCID-Profile: Raman Baweja, Daniel A Waschbusch

Förderung

  • National Center for Advancing Translational Sciences

Zitieren

APA

Baweja, R., Waschbusch, D. A., Carlson, G. A., & Waxmonsky, J. G. (2026). Disruptive Mood Dysregulation Disorder and Its Association with Treatment Trajectories and Outcomes in Youth with Attention-Deficit/Hyperactivity Disorder and Internalizing Disorders. Journal of Child and Adolescent Psychopharmacology, 36(8), 473-482. https://doi.org/10.1177/10445463261428442

Vancouver

Baweja R, Waschbusch DA, Carlson GA, Waxmonsky JG. Disruptive Mood Dysregulation Disorder and Its Association with Treatment Trajectories and Outcomes in Youth with Attention-Deficit/Hyperactivity Disorder and Internalizing Disorders. Journal of Child and Adolescent Psychopharmacology. 2026;36(8):473-482. doi:10.1177/10445463261428442

BibTeX
@article{Baweja2026,
  author = {Baweja, Raman and Waschbusch, Daniel A and Carlson, Gabrielle A and Waxmonsky, James G},
  title = {Disruptive Mood Dysregulation Disorder and Its Association with Treatment Trajectories and Outcomes in Youth with Attention-Deficit/Hyperactivity Disorder and Internalizing Disorders},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2026},
  volume = {36},
  number = {8},
  pages = {473--482},
  doi = {10.1177/10445463261428442}
}
Kostenlos starten →